Androgen Receptor-CaMKK2 Axis in Prostate Cancer and Bone Microenvironment
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Androgen Receptor-CaMKK2 Axis in Prostate Cancer and Bone Microenvironment
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-06-18
DOI
10.3389/fendo.2018.00335
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current perspectives on bone metastases in castrate-resistant prostate cancer
- (2018) Christopher Logothetis et al. CANCER AND METASTASIS REVIEWS
- Inhibition of CaMKK2 Enhances Fracture Healing by Stimulating Indian Hedgehog Signaling and Accelerating Endochondral Ossification
- (2018) Justin N Williams et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Long-Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naïve Prostate Cancer: 3-Year Open Label Followup Results
- (2018) Bertrand Tombal et al. JOURNAL OF UROLOGY
- Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
- (2018) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development and Validation of a Bioanalytical Method to Quantitate Enzalutamide and its Active Metabolite N-Desmethylenzalutamide in Human Plasma
- (2018) Guillemette E. Benoist et al. THERAPEUTIC DRUG MONITORING
- The Epidemiology of Prostate Cancer
- (2018) Claire H. Pernar et al. Cold Spring Harbor Perspectives in Medicine
- AR Signaling in Human Malignancies: Prostate Cancer and Beyond
- (2018) Emmanuel Antonarakis Cancers
- Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns
- (2017) Bram De Laere et al. EUROPEAN UROLOGY
- Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone
- (2017) Hernan Roca et al. JOURNAL OF CLINICAL INVESTIGATION
- Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2017) Sung-Bae Kim et al. LANCET ONCOLOGY
- Beyond the vicious cycle: The role of innate osteoimmunity, automimicry and tumor-inherent changes in dictating bone metastasis
- (2017) Katie L. Owen et al. MOLECULAR IMMUNOLOGY
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
- (2017) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radium‐223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program
- (2017) Oliver Sartor et al. ONCOLOGIST
- Skeletal-related events significantly impact health-related quality of life in metastatic castration-resistant prostate cancer: data from PREVAIL and AFFIRM trials
- (2017) F Saad et al. PROSTATE CANCER AND PROSTATIC DISEASES
- The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation
- (2017) Luisella Cianferotti et al. Oncotarget
- Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer
- (2017) Yun Ye et al. Oncotarget
- Clinical relevance of androgen receptor alterations in prostate cancer
- (2017) Emma Jernberg et al. Endocrine Connections
- AR-Signaling in Human Malignancies: Prostate Cancer and Beyond
- (2017) Michael Schweizer et al. Cancers
- Alteration of osteoblast arrangement via direct attack by cancer cells: New insights into bone metastasis
- (2017) Yumi Kimura et al. Scientific Reports
- Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD
- (2017) Brian York et al. Scientific Reports
- Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression
- (2016) Alicia M. Blessing et al. Autophagy
- Continual reassessment method for dose escalation clinical trials in oncology: a comparison of prior skeleton approaches using AZD3514 data
- (2016) Gareth D. James et al. BMC CANCER
- Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma
- (2016) J. Delgado-Calle et al. CANCER RESEARCH
- MicroRNA and Transcription Factor Gene Regulatory Network Analysis Reveals Key Regulatory Elements Associated with Prostate Cancer Progression
- (2016) Mehdi Sadeghi et al. PLoS One
- The Ca 2+ /Calmodulin/CaMKK2 Axis: Nature's Metabolic CaMshaft
- (2016) Kathrina L. Marcelo et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer
- (2016) Kristine M. Wadosky et al. Oncotarget
- Inhibition of CaMKK2 reverses age-associated decline in bone mass
- (2015) Zachary J. Pritchard et al. BONE
- Tumor-Induced Pressure in the Bone Microenvironment Causes Osteocytes to Promote the Growth of Prostate Cancer Bone Metastases
- (2015) Joseph L. Sottnik et al. CANCER RESEARCH
- A Comprehensive Review on miR-200c, A Promising Cancer Biomarker with Therapeutic Potential
- (2015) Suresh Kumar et al. CURRENT DRUG TARGETS
- The camKK2/camKIV relay is an essential regulator of hepatic cancer
- (2015) Fumin Lin et al. HEPATOLOGY
- Nucleoporin 62 and Ca2+/calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells
- (2015) Loukia G. Karacosta et al. PROSTATE
- Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events
- (2014) M. R. Smith et al. ANNALS OF ONCOLOGY
- Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate Cancer
- (2014) Z. Yu et al. CLINICAL CANCER RESEARCH
- Intercellular Communication by Exosome-Derived microRNAs in Cancer
- (2013) Bethany Hannafon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Transcriptional network of androgen receptor in prostate cancer progression
- (2013) Ken-ichi Takayama et al. INTERNATIONAL JOURNAL OF UROLOGY
- Inhibition of Ca2+/Calmodulin-Dependent Protein Kinase Kinase 2 Stimulates Osteoblast Formation and Inhibits Osteoclast Differentiation
- (2013) Rachel L Cary et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Phase I Study of ARN-509, a Novel Antiandrogen, in the Treatment of Castration-Resistant Prostate Cancer
- (2013) Dana E. Rathkopf et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of Cell Adhesion by a Cadherin-11 Antibody Thwarts Bone Metastasis
- (2013) Y.-C. Lee et al. MOLECULAR CANCER RESEARCH
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
- (2013) T Karantanos et al. ONCOGENE
- CaMKK2: a novel target for shaping the androgen-regulated tumor ecosystem
- (2013) Luigi Racioppi TRENDS IN MOLECULAR MEDICINE
- Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis
- (2013) Younghun Jung et al. Nature Communications
- Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkers
- (2012) Neesha C. Dhani et al. BJU INTERNATIONAL
- ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
- (2012) N. J. Clegg et al. CANCER RESEARCH
- A Regulatory Feedback Loop Between Ca2+/Calmodulin-dependent Protein Kinase Kinase 2 (CaMKK2) and the Androgen Receptor in Prostate Cancer Progression
- (2012) Loukia G. Karacosta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Calcium/Calmodulin-dependent Protein Kinase Kinase 2 Regulates Macrophage-mediated Inflammatory Responses
- (2012) Luigi Racioppi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Calcium/Calmodulin-dependent Protein Kinase Kinase 2: Roles in Signaling and Pathophysiology
- (2012) Luigi Racioppi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2012) Matthew R. Smith et al. JOURNAL OF UROLOGY
- Deletion of CaMKK2 from the Liver Lowers Blood Glucose and Improves Whole-Body Glucose Tolerance in the Mouse
- (2012) Kristin A. Anderson et al. MOLECULAR ENDOCRINOLOGY
- AMPK: a nutrient and energy sensor that maintains energy homeostasis
- (2012) D. Grahame Hardie et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Down-regulation of calcium/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer
- (2012) Takashi Shima et al. PROSTATE
- Generation of Autonomous Activity of Ca2+/Calmodulin-Dependent Protein Kinase Kinase β by Autophosphorylation
- (2011) Hiroshi Tokumitsu et al. BIOCHEMISTRY
- The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
- (2011) Charles E Massie et al. EMBO JOURNAL
- The Ca2+/Calmodulin-Dependent Protein Kinase Kinase, CaMKK2, Inhibits Preadipocyte Differentiation
- (2011) Fumin Lin et al. ENDOCRINOLOGY
- Steps in prostate cancer progression that lead to bone metastasis
- (2011) Jung-Kang Jin et al. INTERNATIONAL JOURNAL OF CANCER
- Ca2+/Calmodulin-dependent Protein Kinase Kinase β Is Regulated by Multisite Phosphorylation
- (2011) Michelle F. Green et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Toremifene Decreases Vertebral Fractures in Men Younger Than 80 Years Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2011) Matthew R. Smith et al. JOURNAL OF UROLOGY
- Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
- (2011) Emma Hörnberg et al. PLoS One
- CaM Kinase Kinase β-Mediated Activation of the Growth Regulatory Kinase AMPK Is Required for Androgen-Dependent Migration of Prostate Cancer Cells
- (2010) Daniel E. Frigo et al. CANCER RESEARCH
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Steroid 5 α-reductase inhibitors targeting BPH and prostate cancer
- (2010) Lucy J. Schmidt et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2010) Matthew R. Smith et al. JOURNAL OF UROLOGY
- Risk of subsequent fracture and mortality within 5 years after a non-vertebral fracture
- (2010) K. M. B. Huntjens et al. OSTEOPOROSIS INTERNATIONAL
- A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
- (2009) Z. Guo et al. CANCER RESEARCH
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
- (2009) Qianben Wang et al. CELL
- Expression of Immunosuppresive B7-H3 Ligand by Hormone-Treated Prostate Cancer Tumors and Metastases
- (2009) G. Chavin et al. CLINICAL CANCER RESEARCH
- Castration-Resistant Prostate Cancer: Locking Up the Molecular Escape Routes
- (2009) R. M. Attar et al. CLINICAL CANCER RESEARCH
- Hypothalamic CaMKK2 Contributes to the Regulation of Energy Balance
- (2008) Kristin A. Anderson et al. Cell Metabolism
- Mineralization and Bone Resorption Are Regulated by the Androgen Receptor in Male Mice
- (2008) Cherie Chiang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Cadherin-11 Promotes the Metastasis of Prostate Cancer Cells to Bone
- (2008) K. Chu et al. MOLECULAR CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started